- Home
- AZTA
AZTA
Azenta Inc.
as 12-17-2024 4:00pm EST
Azenta Inc is a provider of life sciences solutions, enabling impactful breakthroughs and therapies to market faster. It provides a full suite of reliable cold-chain sample management solutions and genomic services across areas such as drug development, clinical research and advanced cell therapies for the industry's top pharmaceutical, biotech, academic and healthcare institutions globally. The company has two reportable segments that are Life Sciences Products and Life Sciences Services. It generates a substantial part of its revenue from its Life Sciences Services segment.
| Founded: | 1978 | Country: | United States |
| Employees: | N/A | City: | BURLINGTON |
| Market Cap: | 2.2B | IPO Year: | 1995 |
| Target Price: | $63.60 | AVG Volume (30 days): | 1.2M |
| Analyst Decision: | Buy | Number of Analysts: | 5 |
| Dividend Yield: | N/A | Dividend Payout Frequency: | N/A |
| EPS: | -3.09 | EPS Growth: | N/A |
| 52 Week Low/High: | $38.82 - $69.16 | Next Earning Date: | 02-05-2025 |
| Revenue: | $656,323,000 | Revenue Growth: | -1.32% |
| Revenue Growth (this year): | -5.39% | Revenue Growth (next year): | 6.17% |
Stock Insider Trading Activity of Azenta Inc. (AZTA)
| Name | Ticker | Relationship | Date | Transaction | AVG Cost Per Share | Shares | Total Value | Securities Owned After Transaction(s) | SEC Form 4 |
|---|---|---|---|---|---|---|---|---|---|
| Madaus Martin D | AZTA | Director | Nov 19 '24 | Buy | $40.77 | 4,940 | $201,403.80 | 7,405 | |
| Joseph Jason | AZTA | SVP, General Counsel, Secy. | Nov 19 '24 | Sell | $40.07 | 1,139 | $45,639.73 | 112,564 | |
| Hughes Violetta | AZTA | VP, Chief Accounting Officer | Nov 19 '24 | Sell | $40.07 | 163 | $6,531.41 | 9,920 | |
| Pirogova Olga | AZTA | SVP and CHRO | Nov 19 '24 | Sell | $40.07 | 548 | $21,958.36 | 19,373 | |
| Zhou Ginger | AZTA | SVP and General Manager, Genom | Nov 19 '24 | Sell | $40.07 | 491 | $19,674.37 | 27,499 | |
| Wang David Dong | AZTA | SVP & GM, SMS | Nov 19 '24 | Sell | $40.07 | 348 | $13,944.36 | 24,114 | |
| Cueto Herman | AZTA | EVP, Chief Financial Officer | Nov 19 '24 | Sell | $40.07 | 712 | $28,529.84 | 23,892 | |
| HIRSCH DIDIER | AZTA | Director | Nov 18 '24 | Buy | $39.50 | 1,000 | $39,500.00 | 3,465 | |
| Cornog William L | AZTA | Director | Nov 18 '24 | Buy | $39.60 | 12,500 | $495,000.00 | 14,755 | |
| Cueto Herman | AZTA | EVP, Chief Financial Officer | Oct 17 '24 | Sell | $43.68 | 1,595 | $69,669.60 | 23,892 |
Latest Azenta Inc. News
AZTA Breaking Stock News: Dive into AZTA Ticker-Specific Updates for Smart Investing
Argus Research
8 days ago
AZTA: Lowering target price to $37.00
Simply Wall St.
9 days ago
Is It Time To Consider Buying Azenta, Inc. (NASDAQ:AZTA)?
Argus Research
15 days ago
AZTA: Raising target price to $38.00
TipRanks
19 days ago
Azenta, Inc. Navigates Global Data Protection Laws Amid Business Risks
Argus Research
a month ago
Daily – Vickers Top Buyers & Sellers for 11/20/2024
PR Newswire
a month ago
Flex Set to Join S&P MidCap 400; Azenta and Concentra Group Holdings to Join S&P SmallCap 600
Simply Wall St.
a month ago
Azenta, Inc. (NASDAQ:AZTA) Analysts Just Slashed This Year's Revenue Estimates By 14%
Simply Wall St.
a month ago
Azenta, Inc. (NASDAQ:AZTA) Analysts Are Cutting Their Estimates: Here's What You Need To Know
Compare AZTA vs Leading Stocks
Share on Social Networks:
Disclaimer
The information presented on this page, "AZTA Azenta Inc. - Stocks Price | History | Analysis", including historical data, forecasts, news, insider information, and predictions, is provided for educational purposes only. It should not be considered as financial advice or a recommendation to buy or sell any securities. Decisions regarding investments should be made only after careful consideration and consultation with a qualified financial advisor. We do not endorse or guarantee the accuracy or reliability of the information provided, and we disclaim any liability for financial losses incurred as a result of decisions made based on the information presented.